Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · IEX Real-Time Price · USD
6.51
-0.02 (-0.31%)
At close: Jul 19, 2024, 4:00 PM
6.45
-0.06 (-0.92%)
After-hours: Jul 19, 2024, 5:58 PM EDT

Acelyrin Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021
Selling, General & Admin
79.0166.1813.553.56
Research & Development
246355.8955.6338.23
Operating Expenses
325.01422.0669.1841.79
Operating Income
-325.01-422.06-69.18-41.79
Other Expense / Income
-84.84-40.42-4.410.05
Pretax Income
-240.16-381.64-64.77-41.84
Net Income
-240.16-381.64-64.77-41.84
Shares Outstanding (Basic)
987021
Shares Outstanding (Diluted)
987021
Shares Change
377.81%4410.31%126.58%-
EPS (Basic)
-2.38-5.43-41.59-60.87
EPS (Diluted)
-2.38-5.43-41.59-60.87
Free Cash Flow
-196.79-172-61.52-4.98
Free Cash Flow Per Share
-2.01-2.45-39.50-7.24
EBITDA
-239.81-381.37-64.77-41.84
Depreciation & Amortization
0.350.2700
EBIT
-240.16-381.64-64.77-41.84
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).